A CLINICAL TRIAL INVESTIGATING THE EFFECTS OF SOUVENAID IN PRODROMAL ALZHEIMER'S DISEASE: PROGRESS AND BASELINE CHARACTERISTICS OF THE LIPIDIDIET STUDY

被引：3
|
作者：
Soininen, Hilkka [1 ]
Visser, P. J. [2 ]
Kivipelto, M. [3 ]
van Hees, A. [4 ]
Rouws, C. [4 ]
Hartmann, T. [5 ]
机构：
[1] Univ Eastern Finland, Kuopio, Finland
[2] Univ Maastricht, Maastricht, Netherlands
[3] Karolinska Inst, Stockholm, Sweden
[4] Nutricia, Wageningen, Netherlands
[5] Univ Saarland, Homburg, Germany
来源：
NEUROBIOLOGY OF AGING | 2014年 / 35卷
关键词：
Alzheimer's disease; Intervention; Cognition; Memory; Biomarker; MRI;
D O I：
10.1016/j.neurobiolaging.2014.01.108
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] A CLINICAL TRIAL INVESTIGATING THE EFFECTS OF FORTASYN CONNECT (SOUVENAID) IN PRODROMAL ALZHEIMER'S DISEASE: RESULTS OF THE LIPIDIDIET STUDY
    Soininen, Hilkka
    Visser, Pieter
    Kivipelto, Miia
    Hartmann, Tobias
    NEUROBIOLOGY OF AGING, 2016, 39 : S23 - S23
  • [2] Baseline Characteristics of Subjects with Prodromal Alzheimer's Disease: The LipiDiDiet Study
    Freund-Levi, Y.
    Visser, P. J.
    Kivipelto, M.
    Wieggers, R. L.
    Hartmann, T.
    Soininen, H.
    ANNALS OF NEUROLOGY, 2012, 72 : S53 - S54
  • [3] Baseline characteristics of subjects with prodromal Alzheimer's disease: the LipiDiDiet study
    Freund-Levi, Y.
    Visser, P. J.
    Kivipelto, M.
    Kamphuis, P. J. G. H.
    Wieggers, R. L.
    Hartmann, T.
    Soininen, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 112 - 112
  • [4] 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease
    Soininen, Hilkka
    Solomon, Alina
    Visser, Pieter Jelle
    Hendrix, Suzanne B.
    Blennow, Kaj
    Kivipelto, Miia
    Hartmann, Tobias
    ALZHEIMERS & DEMENTIA, 2021, 17 (01) : 29 - 40
  • [5] MEDICAL NUTRITION IN ALZHEIMER'S DISEASE: BASELINE CHARACTERISTICS OF SOUVENAID® CLINICAL STUDIES
    Scheltens, P.
    Kamphuis, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 82 - 82
  • [6] 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease (vol 17, pg 29, 2021)
    Soininen, Hilkka
    Hallikainen, Ilona
    Hallikainen, Merja
    Helisalmi, Seppo
    Lappalainen, Tarja
    Liu, Yawu
    Paajanen, Teemu
    ALZHEIMERS & DEMENTIA, 2021, 17 (05) : 909 - 909
  • [7] Alzheimer’s Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer’s Disease
    Suzanne B. Hendrix
    H. Soininen
    A. M. J. van Hees
    N. Ellison
    P. J. Visser
    A. Solomon
    A. Attali
    K. Blennow
    M. Kivipelto
    T. Hartmann
    The Journal of Prevention of Alzheimer's Disease, 2019, 6 : 232 - 236
  • [8] Alzheimer's Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease
    Hendrix, S. B.
    Soininen, H.
    van Hees, A. M. J.
    Ellison, N.
    Visser, P. J.
    Solomon, A.
    Attali, A.
    Blennow, K.
    Kivipelto, M.
    Hartmann, T.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2019, 6 (04): : 232 - 236
  • [9] Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease
    Javier Mar
    Ania Gorostiza
    Oliver Ibarrondo
    Igor Larrañaga
    Arantzazu Arrospide
    Pablo Martinez-Lage
    Myriam Soto-Gordoa
    Alzheimer's Research & Therapy, 12
  • [10] Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer's disease
    Mar, Javier
    Gorostiza, Ania
    Ibarrondo, Oliver
    Larranaga, Igor
    Arrospide, Arantzazu
    Martinez-Lage, Pablo
    Soto-Gordoa, Myriam
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
12345